Dasiglucagon rapidly reverses hypoglycaemia in type 1 diabetes
The ready-to-use, next-generation glucagon analogue in aqueous formulation, namely dasiglucagon, has performed well in a phase III study of adult patients with type 1 diabetes, resulting in fast and effective reversal of hypoglycaemia.